Found 48 matching trials
A Phase I Study to Evaluate Pharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous in Patients With Active Crohn's Disease and Ulcerative Colitis PHASE1 Phase 1 randomized, open-label, multicenter, parallel-group study designed ...
Show More Location
Yeungnam University Hospital
Learn More & Join Trial
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis PHASE4 Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) that ...
Show More Location
Centre Hospitalier Universitaire d'Amiens-Picardie
Learn More & Join Trial
Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis Suppurativa EARLY_PHASE1 The aim of this clinical trial is to assess the efficacy and safety of Infl...
Show More Location
Services Institute of Medical Sciences
Learn More & Join Trial
Evaluate if Response to Infliximab or Adalimumab May be Regained With an Immunomodulator NA The immunogenicity of anti-tumor necrosis factor alpha (anti-TNF) therapy i...
Show More Location
Indiana University Hospital
Learn More & Join Trial
Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis PHASE4 Background:
* Rheumatoid arthritis (RA) is often treated with drugs known ...
Show More Location
Georgetown University Medical Center
Learn More & Join Trial
CHronic Nonbacterial Osteomyelitis International Registry N/A The objective of the study is to establish a prospective disease registry f...
Show More Location
Seattle Children's Hospital
Learn More & Join Trial
A Phase I/III Study to Evaluate Efficacy, PK and Safety Between CT-P13 SC and CT-P13 IV in Patients With Active RA PHASE3 This is a Phase I/III Study to Evaluate Efficacy, Pharmacokinetics and Safe...
Show More Location
Hanyang University Medical Center
Learn More & Join Trial
Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission. PHASE2 The purpose of this study is to determine if PF-06687234 is effective and s...
Show More Location
Dothan Surgery Center
Learn More & Join Trial
Management of Moderate POstoperative Recurrence in Crohn's Disease: a randoMizEd contROLled Trial of Therapeutic Escalation, the POMEROL Trial. (POMEROL) PHASE4 Study type : A 30 months, multicentre, open-label strategic randomized cont...
Show More Learn More & Join Trial
Effect of Infliximab on the Efficacy of Peg-Intron/Ribavirin in Patients With Hepatitis C (Study P04257AM4)(COMPLETED) PHASE3 This is a Phase IIIB, randomized, prospective, multicenter, single-country,...
Show More Location
Multiple Locations
Learn More & Join Trial